Unnamed: 0,title,date,stock,sentiment
26984.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,ADMP,positive
26985.0,Adamis Pharma Highlights Publication Of Pharmacokinetic Study Comparing ZIMHI To Current 2 mg Intramuscular Dose Of Naloxone,2020-05-27 09:02:00-04:00,ADMP,neutral
26986.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,ADMP,positive
26987.0,"Adamis Pharmaceuticals Q1 EPS $(0.110) Misses $(0.040) Estimate, Sales $4.663M Miss $6.870M Estimate",2020-05-18 16:39:00-04:00,ADMP,negative
26988.0,Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA,2020-05-18 09:00:00-04:00,ADMP,neutral
26989.0,"The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows",2020-05-17 12:30:00-04:00,ADMP,positive
26990.0,"Maxim Group Upgrades Adamis Pharmaceuticals to Buy, Announces $1.5 Price Target",2020-05-13 11:34:00-04:00,ADMP,neutral
26991.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-05-13 07:33:00-04:00,ADMP,neutral
26992.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,ADMP,negative
26993.0,"Shares of several healthcare companies are trading higher amid continued economic optimism as some US states ease lockdown restrictions. While jobless claims came in worse than estimates, figures were lower than in prior weeks.",2020-05-07 11:25:00-04:00,ADMP,positive
26994.0,Adamis Pharma Highlights Publication Of 'The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys' In 'Molecules',2020-04-23 09:06:00-04:00,ADMP,neutral
26995.0,Adamis Pharma Reports Production Of Added Drugs By Its US Compounding Subsidiary To Aid In Coronavirus Pandemic,2020-04-21 09:11:00-04:00,ADMP,neutral
26996.0,"Adamis Pharma Reports Its Drug Outsourcing Facility, US Compounding, Has Shifted Part Of Its Production To Provide Medical-Grade Hand Sanitizers To Hospitals, Health Care Workers To Assist In Fight Against Coronavirus",2020-04-01 09:04:00-04:00,ADMP,positive
26997.0,17 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-31 07:58:00-04:00,ADMP,neutral
26998.0,"Adamis Pharmaceuticals FY19 Sales $22.1M Up From $15.1M YoY, Cash At End Of Year $8.8M",2020-03-30 16:41:00-04:00,ADMP,neutral
26999.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-25 07:35:00-04:00,ADMP,neutral
27000.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ADMP,negative
27001.0,94 Biggest Movers From Friday,2020-02-24 04:53:00-05:00,ADMP,neutral
27002.0,68 Stocks Moving In Friday's Mid-Day Session,2020-02-21 12:29:00-05:00,ADMP,neutral
27003.0,"Adamis Pharma Prices 11.6M Common Stock, Warrants Offering At $0.58/Unit",2020-02-21 09:15:00-05:00,ADMP,neutral
27004.0,Adamis Pharmaceuticals Says Believes It Can Generate Additional Info Requested By FDA And Resubmit ZIMHI NDA,2020-02-19 09:07:00-05:00,ADMP,neutral
27005.0,43 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-28 23:40:00-05:00,ADMP,neutral
27006.0,18 Drug Manufacturers—Specialty & Generic Stocks Moving In Wednesday's Session,2020-01-22 13:28:00-05:00,ADMP,neutral
27007.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,ADMP,neutral
27008.0,"Adamis Pharmaceuticals Sees Prelim. Q4 Product Sales $16.3M, FY19 Product Sales $54.6M",2020-01-08 09:19:00-05:00,ADMP,neutral
27009.0,Adamis Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2020-01-06 11:26:00-05:00,ADMP,positive
27010.0,"Adamis Pharma Offers Update On ZIMHI New Drug Application Resubmission Process: Co. Sent Responses To FDA Related To Complete Response Letter, Requested Type-A Meeting, Is Currently Awaiting Response From FDA",2019-12-19 09:05:00-05:00,ADMP,neutral
27011.0,60 Biggest Movers From Yesterday,2019-11-27 05:03:00-05:00,ADMP,neutral
27012.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-11-26 12:09:00-05:00,ADMP,neutral
27013.0,Adamis Pharmaceuticals shares are trading lower after Raymond James downgraded the stock from Outperform to Market Perform.,2019-11-26 10:41:00-05:00,ADMP,neutral
27014.0,"Benzinga's Top Upgrades, Downgrades For November 26, 2019",2019-11-26 09:59:00-05:00,ADMP,positive
27015.0,45 Biggest Movers From Yesterday,2019-11-26 07:05:00-05:00,ADMP,neutral
27016.0,Raymond James Downgrades Adamis Pharmaceuticals to Market Perform,2019-11-26 06:00:00-05:00,ADMP,neutral
27017.0,Mid-Afternoon Market Update: Dow Rises 150 Points; Sorrento Therapeutics Shares Spike Higher,2019-11-25 15:20:00-05:00,ADMP,positive
27018.0,Maxim Group Downgrades Adamis Pharmaceuticals to Hold,2019-11-25 12:54:00-05:00,ADMP,neutral
27019.0,33 Stocks Moving In Monday's Mid-Day Session,2019-11-25 12:28:00-05:00,ADMP,neutral
27020.0,Mid-Day Market Update: Medicines Company Jumps Following Acquisition News; CymaBay Therapeutics Shares Plunge,2019-11-25 12:10:00-05:00,ADMP,positive
27021.0,Adamis Pharmaceuticals shares are trading lower after the company reported it received a complete response letter from the FDA for its ZIMHI. The FDA stated it cannot approve the ZIMHI in its present form and provided suggested needed for resubmission.,2019-11-25 08:47:00-05:00,ADMP,neutral
27022.0,36 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-25 08:40:00-05:00,ADMP,neutral
27023.0,Adamas Pharma Receives Complete Response Letter From FDA Related To ZIMHI,2019-11-25 08:02:00-05:00,ADMP,neutral
27024.0,Adamis Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action. NOTE: The stock is trading on above-average volume.,2019-11-22 14:57:00-05:00,ADMP,positive
27025.0,Adamis Pharmaceuticals Q3 Sales $5.9M Miss $6.37M Estimate; Cash And Cash Equivalents At End Of Q3 $12.1M,2019-11-12 16:30:00-05:00,ADMP,negative
27026.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,ADMP,neutral
27027.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,ADMP,positive
27028.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-07 08:04:00-05:00,ADMP,neutral
27029.0,Adamis Pharmaceuticals shares are trading higher on seemingly no company-specific news.,2019-11-06 10:15:00-05:00,ADMP,neutral
27030.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-06 07:52:00-05:00,ADMP,neutral
27031.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,ADMP,negative
27032.0,﻿Adamis Pharmaceuticals shares are trading lower as a potential sell-off after the company's stock increased roughly 15% yesterday ahead of the FDA decision on higher doses of naloxone.,2019-11-01 10:08:00-04:00,ADMP,positive
27033.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-01 08:21:00-04:00,ADMP,neutral
27034.0,Adamis Pharmaceuticals shares are trading higher on seemingly no company-specific news.,2019-10-31 11:49:00-04:00,ADMP,neutral
27035.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,ADMP,positive
27036.0,"Seeing Bearish Blog Post On Adamis Pharmaceuticals, Citing 'history of the company coming up short and disappointing shareholders'",2019-10-29 14:30:00-04:00,ADMP,negative
27037.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,ADMP,neutral
27038.0,Adamis Pharmaceuticals 8K Filing Showing Notice Of Delisting,2019-10-16 16:39:00-04:00,ADMP,neutral
27039.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-16 10:55:00-04:00,ADMP,negative
27040.0,Stocks That Hit 52-Week Lows On Friday,2019-10-11 10:22:00-04:00,ADMP,negative
27041.0,"The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout",2019-10-11 08:14:00-04:00,ADMP,positive
27042.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-10 11:08:00-04:00,ADMP,negative
27043.0,16 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-07 08:09:00-04:00,ADMP,neutral
27044.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,ADMP,positive
27045.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-01 14:35:00-04:00,ADMP,negative
27046.0,Adamis Pharmaceuticals Announces Commercial Partnership With Emerge Health For SYMJEPI® In Australia And New Zealand,2019-10-01 09:02:00-04:00,ADMP,neutral
27047.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,ADMP,neutral
27048.0,Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting,2019-09-26 09:05:00-04:00,ADMP,neutral
27049.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-11 08:21:00-04:00,ADMP,neutral
27050.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-10 09:02:00-04:00,ADMP,neutral
27051.0,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication",2019-09-06 07:27:00-04:00,ADMP,neutral
27052.0,"The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug",2019-09-05 08:12:00-04:00,ADMP,neutral
27053.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,ADMP,negative
27054.0,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books",2019-09-04 07:08:00-04:00,ADMP,positive
27055.0,Adamis Pharmaceuticals Announces Completion Of Pharmacokinetic Studies Comparing Naloxone To Generic Comparator,2019-09-03 09:12:00-04:00,ADMP,neutral
27056.0,Stocks That Hit 52-Week Lows On Thursday,2019-08-29 11:19:00-04:00,ADMP,negative
27057.0,Adamis Pharmaceuticals Strengthens Patent Portfolio For US Compounding Subsidiary,2019-08-14 09:05:00-04:00,ADMP,positive
27058.0,Adamis Pharmaceuticals Q2 Sales $5.8M Miss $5.84M Estimate,2019-08-08 16:59:00-04:00,ADMP,negative
27059.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,ADMP,neutral
27060.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,ADMP,negative
27061.0,100 Biggest Movers From Yesterday,2019-08-02 05:53:00-04:00,ADMP,neutral
27062.0,72 Stocks Moving In Thursday's Mid-Day Session,2019-08-01 12:16:00-04:00,ADMP,neutral
27063.0,Stocks that Reached Yearly Lows Thursday Morning,2019-08-01 11:09:00-04:00,ADMP,negative
27064.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-01 09:38:00-04:00,ADMP,neutral
27065.0,Adamis Pharmaceuticals Prices 12M Unit Offering At $1/Share,2019-08-01 09:34:00-04:00,ADMP,neutral
27066.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,ADMP,negative
27067.0,28 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-01 04:20:00-04:00,ADMP,neutral
27068.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,ADMP,neutral
27069.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,ADMP,neutral
27070.0,B. Riley FBR Upgrades Adamis Pharmaceuticals to Neutral,2019-07-23 11:48:00-04:00,ADMP,neutral
27071.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,ADMP,negative
27072.0,Adamis Pharmaceuticals Announces That Adamis And KaléO Agreed To Settle All Previously Announced Litigation Between The Parties,2019-07-18 13:54:00-04:00,ADMP,positive
27073.0,"Benzinga's Top Upgrades, Downgrades For July 16, 2019",2019-07-16 09:05:00-04:00,ADMP,positive
27074.0,Adamis Pharmaceuticals shares are trading lower after B. Riley downgraded the stock from Neutral to Sell and lowered its price target from $1.90 to $1.10.,2019-07-16 08:44:00-04:00,ADMP,negative
27075.0,"B. Riley Downgrades Adamis Pharmaceuticals to Sell, Lowers Price Target to $1.1",2019-07-16 07:53:00-04:00,ADMP,negative
27076.0,"Adamis Pharma Shares Spike To High, Up 2.3%; Traders Circulate Seeking Alpha Blog Post 'Sandoz And Adamis Pharmaceuticals Will Benefit From Epipen Shortage'",2019-07-15 10:00:00-04:00,ADMP,positive
27077.0,Adamis Pharmaceuticals shares are trading higher after the company announced the U.S. retail launch of SYMJEPI.,2019-07-09 11:21:00-04:00,ADMP,positive
27078.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,ADMP,negative
27079.0,Adamis Pharma Reports Filed 2 Motions In Delaware Court Related To kaleo's Patent Infringement Suit Regarding ZIMHI,2019-06-27 09:08:00-04:00,ADMP,negative
27080.0,"Companies Which Will Be Presenting At LD Micro's 9th Annual Micro Invitational Tues., Jun. 4, 2019",2019-06-03 16:57:00-04:00,ADMP,neutral
27081.0,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug",2019-05-30 07:33:00-04:00,ADMP,positive
27082.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,ADMP,neutral
27083.0,"The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice",2019-05-24 07:44:00-04:00,ADMP,neutral
27084.0,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",2019-05-23 07:37:00-04:00,ADMP,neutral
27085.0,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",2019-05-22 07:34:00-04:00,ADMP,neutral
27086.0,50 Biggest Movers From Yesterday,2019-05-22 05:12:00-04:00,ADMP,neutral
27087.0,36 Stocks Moving In Tuesday's Mid-Day Session,2019-05-21 12:31:00-04:00,ADMP,neutral
27088.0,Adamis Pharmaceuticals shares are trading lower after the company announced patent litigation regarding its higher dose naloxone injection product.,2019-05-21 09:52:00-04:00,ADMP,negative
27089.0,Adamis Pharma Reports Patent Litigation Related To Higher Dose Naloxone Injection Product,2019-05-21 08:35:00-04:00,ADMP,negative
27090.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,ADMP,negative
27091.0,Adamis Pharmaceuticals Announces Conditional Acceptance By FDA Of Proprietary Name For Higher Dose Naloxone Product,2019-05-14 09:03:00-04:00,ADMP,positive
27092.0,"Adamis Pharmaceuticals Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $4.906M Miss $5.79M Estimate",2019-05-09 17:36:00-04:00,ADMP,negative
27093.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,ADMP,neutral
27094.0,60 Biggest Movers From Yesterday,2019-03-19 05:24:00-04:00,ADMP,neutral
27095.0,48 Stocks Moving In Monday's Mid-Day Session,2019-03-18 12:33:00-04:00,ADMP,neutral
27096.0,24 Stocks Moving In Monday's Pre-Market Session,2019-03-18 08:07:00-04:00,ADMP,neutral
27097.0,32 Stocks Moving In Friday's Pre-Market Session,2019-03-15 08:25:00-04:00,ADMP,neutral
27098.0,"The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA",2019-03-15 07:39:00-04:00,ADMP,positive
27099.0,Adamis Pharma Reports FDA Accepted Review Of New Drug Application Of Higher Dose Naloxone Injection Product Candidate,2019-03-14 16:56:00-04:00,ADMP,positive
27100.0,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",2019-02-27 08:13:00-05:00,ADMP,neutral
27101.0,Adamis Pharma Highlights Publication Of Rationale For Higher Dose Naloxone Product To Counter Current Opioid Epidemic,2019-02-20 09:06:00-05:00,ADMP,neutral
27102.0,Adamis Pharma Shares Unaffected Following 13G Filing From First Manhattan Showing 7.23% Stake,2019-02-11 10:34:00-05:00,ADMP,positive
27103.0,48 Biggest Movers From Yesterday,2019-01-18 05:06:00-05:00,ADMP,neutral
27104.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-01-17 12:45:00-05:00,ADMP,neutral
27105.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,ADMP,positive
27106.0,22 Stocks Moving In Thursday's Pre-Market Session,2019-01-17 07:58:00-05:00,ADMP,neutral
27107.0,5 Stocks Moving In Wednesday's After-Hours Session,2019-01-16 17:08:00-05:00,ADMP,neutral
27108.0,"Novartiz Division, Sandoz, Announces Launch Of SYMJEPI Epinephrine Injection In US; Sandoz Is A Partner Of Adamiz Pharmaceuticals",2019-01-16 16:09:00-05:00,ADMP,neutral
27109.0,"Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James",2019-01-02 10:21:00-05:00,ADMP,neutral
27110.0,A Peek Into The Markets: US Stock Futures Tumble,2019-01-02 07:37:00-05:00,ADMP,neutral
27111.0,"5 Stocks To Watch For January 2, 2019",2019-01-02 04:36:00-05:00,ADMP,neutral
27112.0,Adamis Pharma Reports Submission Of New Drug Application For Its Naloxone Pre-Filled Syringe,2018-12-31 16:03:00-05:00,ADMP,neutral
27113.0,Novartis to Launch Adamis' EpiPen Rival in U.S. in 2019,2018-12-07 04:25:00-05:00,ADMP,neutral
27114.0,Adamis Pharmaceuticals Announces Launch Of SYMJEPI Planned For Early Q1 2019,2018-12-06 09:32:00-05:00,ADMP,neutral
27115.0,52 Biggest Movers From Friday,2018-12-03 05:42:00-05:00,ADMP,neutral
27116.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,ADMP,neutral
27117.0,B. Riley FBR on Adamis Pharmaceuticals: Downgrading Primarily Due To Slower-Than-Expected Domestic Commercial Launch Of Symjep,2018-11-12 12:24:00-05:00,ADMP,neutral
27118.0,10 Biggest Price Target Changes For Monday,2018-11-12 09:54:00-05:00,ADMP,neutral
27119.0,"B. Riley FBR Downgrades Adamis Pharmaceuticals to Neutral, Lowers Price Target to $2.50",2018-11-12 05:44:00-05:00,ADMP,negative
27120.0,Adamis Pharmaceuticals Q3 Sales $3.8M Miss $5.23M Estimate,2018-11-09 16:46:00-05:00,ADMP,negative
27121.0,46 Biggest Movers From Friday,2018-10-01 04:20:00-04:00,ADMP,neutral
27122.0,34 Stocks Moving In Friday's Mid-Day Session,2018-09-28 12:41:00-04:00,ADMP,neutral
27123.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,ADMP,positive
27124.0,6 Stocks Moving In Thursday's After-Hours Session,2018-09-27 16:49:00-04:00,ADMP,neutral
27125.0,"Adamis Pharma Shares Resume Trade, Up 3.7%",2018-09-27 16:25:00-04:00,ADMP,positive
27126.0,Adamis Pharma Shares To Resume Trade At 4:25 p.m. EDT,2018-09-27 16:11:00-04:00,ADMP,positive
27127.0,Adamis Pharma Receives FDA Approval For Symjepi - Low Dose,2018-09-27 16:07:00-04:00,ADMP,positive
27128.0,Adamis Pharma Shares Halted News Pending,2018-09-27 13:36:00-04:00,ADMP,positive
27129.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,ADMP,neutral
27130.0,REMINDER: Adamis Pharma Has FDA PDUFA Date Today For Symjepi - Low Dose,2018-09-27 06:28:00-04:00,ADMP,negative
27131.0,51 Biggest Movers From Yesterday,2018-09-25 04:53:00-04:00,ADMP,neutral
27132.0,"The Week Ahead: Nike Earnings, FDA Debates E-Cig Industry, SurveyMonkey IPOs",2018-09-24 13:45:00-04:00,ADMP,neutral
27133.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,ADMP,neutral
27134.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2018-09-02 09:41:00-04:00,ADMP,neutral
27135.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,2018-08-31 15:06:00-04:00,ADMP,neutral
27136.0,UPDATE: Adamis Highlights 7 Upcoming Future Milestones,2018-08-27 12:03:00-04:00,ADMP,neutral
27137.0,"Adamis Pharma Offers Business Update, Discusses SYMJEPI 0.30mg, Says Co. 'remains excited about the potential for our FDA approved Symjepi'",2018-08-27 12:03:00-04:00,ADMP,positive
27138.0,50 Biggest Movers From Yesterday,2018-08-23 05:10:00-04:00,ADMP,neutral
27139.0,35 Stocks Moving In Wednesday's Mid-Day Session,2018-08-22 12:23:00-04:00,ADMP,neutral
27140.0,"Stocks Which Set New 52-Week Low Yesterday, August 21st",2018-08-22 09:11:00-04:00,ADMP,negative
27141.0,"Stocks Which Set New 52-Week Low Tues., Aug. 21, 2018",2018-08-21 14:56:00-04:00,ADMP,negative
27142.0,50 Biggest Movers From Friday,2018-08-20 05:33:00-04:00,ADMP,neutral
27143.0,23 Stocks Moving In Friday's Pre-Market Session,2018-08-17 08:02:00-04:00,ADMP,neutral
27144.0,45 Biggest Movers From Yesterday,2018-08-17 05:37:00-04:00,ADMP,neutral
27145.0,"Adamis Pharma Q2 Net Loss $9.7M vs $4.9M In Same Qtr. Last Year, Sales $3.9M vs $3.8M Year Over Year",2018-08-10 09:01:00-04:00,ADMP,negative
27146.0,Adamis Pharmaceuticals Prices ~11.67M Share Common Stock Offering At $3.00/Share For Gross Proceeds Of Approximately $35M,2018-08-02 09:06:00-04:00,ADMP,negative
27147.0,Adamis Pharmaceuticals Announces Proposed Public Common Stock Offering; No Size Disclosed,2018-08-01 16:35:00-04:00,ADMP,negative
27148.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,ADMP,neutral
27149.0,"Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline, Co. Says It Intends To Submit New Drug Application To The FDA With Goal Of Filing An NDA By Year End",2018-07-23 09:03:00-04:00,ADMP,negative
27150.0,"William Blair Views 4 Biotech/Pharma Stocks As 'Top Picks': Adamas Pharma, Aclaris Therapeutics, Biodelivery Sciences, Exelixis",2018-07-19 06:26:00-04:00,ADMP,positive
27151.0,Adamis Pharmaceuticals S-1 Shows Filing For Up To $150M Mixed Shelf Offering,2018-07-09 17:15:00-04:00,ADMP,neutral
27152.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Tues., Jul. 3, 2018",2018-07-03 10:16:00-04:00,ADMP,positive
27153.0,20 Stocks Moving In Tuesday's Pre-Market Session,2018-07-03 08:04:00-04:00,ADMP,neutral
27154.0,44 Biggest Movers From Yesterday,2018-07-03 05:54:00-04:00,ADMP,neutral
27155.0,Mid-Afternoon Market Update: Dow Down Over 150 Points; Radisys Shares Spike Higher,2018-07-02 14:18:00-04:00,ADMP,positive
27156.0,38 Stocks Moving In Monday's Mid-Day Session,2018-07-02 12:29:00-04:00,ADMP,neutral
27157.0,Mid-Day Market Update: Adamis Pharma Gains Amid New Partnership With Novartis To Commercialize Symjepi; MiMedx Shares Slide,2018-07-02 12:01:00-04:00,ADMP,positive
27158.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Mon., Jul. 2, 2018",2018-07-02 10:44:00-04:00,ADMP,positive
27159.0,Adamis Pharma Soars 60% Amid New Partnership With Novartis To Commercialize Symjepi,2018-07-02 10:14:00-04:00,ADMP,neutral
27160.0,Mid-Morning Market Update: Markets Open Lower; Randa Proposes To Acquire Perry Ellis,2018-07-02 10:09:00-04:00,ADMP,negative
27161.0,Adamis Pharmaceuticals Shares Rise 35.9% After Co. Reached Agreement With Sandoz To Commercialize Symjepi,2018-07-02 09:56:00-04:00,ADMP,positive
27162.0,28 Stocks Moving In Monday's Pre-Market Session,2018-07-02 08:06:00-04:00,ADMP,neutral
27163.0,Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement with Sandoz for Symjepi,2018-07-01 20:03:00-04:00,ADMP,positive
27164.0,50 Biggest Movers From Yesterday,2018-06-21 04:34:00-04:00,ADMP,neutral
27165.0,"Maxim Group Maintains Buy on Adamis Pharmaceuticals, Raises Price Target to $10",2018-05-14 14:34:00-04:00,ADMP,neutral
27166.0,Maxim Raises Adamis Pharmaceuticals Price Target From $5 To $10; Maintains Buy Rating,2018-05-11 11:44:00-04:00,ADMP,neutral
27167.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,ADMP,negative
27168.0,Adamis Pharmaceuticals Q1 EPS $(0.23) Misses $(0.19) Estimate,2018-05-10 17:55:00-04:00,ADMP,negative
27169.0,"H.C. Wainwright Initiates Coverage On Adamis Pharmaceuticals with Buy Rating, Announces $7.00 Price Target",2018-04-23 08:58:00-04:00,ADMP,neutral
27170.0,28 Stocks Moving In Friday's Pre-Market Session,2018-03-16 08:04:00-04:00,ADMP,neutral
27171.0,Adamis Pharma Reports Publication Of New Human Factors Study Comparing Symjepi To Market-Leading Product,2018-03-08 09:02:00-05:00,ADMP,neutral
27172.0,Adamis Pharma Highlights Excerpts From Abstract Of Presentation 'Human Factors Study of A Newly Approved Epinephrin...' At AAAAI Congress,2018-03-06 09:11:00-05:00,ADMP,positive
27173.0,45 Biggest Movers From Yesterday,2018-03-02 05:03:00-05:00,ADMP,neutral
27174.0,46 Biggest Movers From Yesterday,2018-02-26 05:08:00-05:00,ADMP,neutral
27175.0,Adamis Pharmaceuticals Shares Up 40% As Co. Said It's In Discussions With 2 Potential Partners For Commercialization Of Symjepi Allergy Treatment,2018-02-23 12:41:00-05:00,ADMP,positive
27176.0,40 Stocks Moving In Friday's Mid-Day Session,2018-02-23 12:26:00-05:00,ADMP,neutral
27177.0,"Adamis Pharma Offers Update On Commercialization Plans For Symjepi: 'While the process is still onging, we are now in discussions with two potential partners.'",2018-02-23 09:07:00-05:00,ADMP,neutral
27178.0,46 Biggest Movers From Yesterday,2018-02-16 05:19:00-05:00,ADMP,neutral
27179.0,Adamis Pharma Shares Down ~14%; 13G/A Filing Wednesday Shows Perceptive Advisors Reporting 0% Stake,2018-02-15 13:44:00-05:00,ADMP,positive
27180.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-02-15 12:11:00-05:00,ADMP,neutral
27181.0,Adamis Pharmaceuticals Announces FDA Acceptance for Review for the  Supplemental New Drug Application of Its Low Dose Symjepi Product Candidate,2018-02-12 09:02:00-05:00,ADMP,positive
27182.0,28 Stocks Moving In Monday's Pre-Market Session,2018-02-05 08:07:00-05:00,ADMP,neutral
27183.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-01-04 08:27:00-05:00,ADMP,neutral
27184.0,36 Biggest Movers From Yesterday,2017-12-06 05:19:00-05:00,ADMP,neutral
27185.0,Adamis Pharmaceuticals Announces Submission of IND To FDA For NaloxoneCompound,2017-12-04 16:11:00-05:00,ADMP,neutral
27186.0,"BZ NOTE: Adamis' Sympei Had Previously (On Jun. 15, 2017) Been Described As 'lower cost, small size and user-friendly design' By Co. CEO; Comment In Fri. Co. Press Release Does Not Seem To Be New Information",2017-12-01 09:36:00-05:00,ADMP,neutral
27187.0,"Watching Adamis, Competitor Mylan Shares Following Adamis Release Previewing Results Of Symjepi Study Will Be Presented At AAAAI; Co. CEO Described Symjepi Results As Demonstrating Device Is 'easy to use, small and intuitive'",2017-12-01 09:32:00-05:00,ADMP,positive
27188.0,38 Biggest Movers From Yesterday,2017-12-01 04:44:00-05:00,ADMP,neutral
27189.0,30 Stocks Moving In Thursday's Mid-Day Session,2017-11-30 12:49:00-05:00,ADMP,neutral
27190.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-11-30 08:07:00-05:00,ADMP,neutral
27191.0,Adamis Pharma Shares Up 11.3% Following News Co. Submitted Prior Approval Supplement For Pediatric Version Of Symjepi,2017-11-29 17:06:00-05:00,ADMP,positive
27192.0,Adamis Pharma Reports Submission Of Prior Approval Supplement To FDA For Pediatric Version Of Symjepi,2017-11-29 16:15:00-05:00,ADMP,positive
27193.0,Adamis Pharmaceutical Shares Down 5.95% As Social Media Mentions Exhibit Investor Anxiety Around Prospects Of Co. Establishing Pharma Partnership By Year End,2017-11-27 12:26:00-05:00,ADMP,positive
27194.0,Adamas Pharma Shares Down 5% Amid No News; Stock Down ~24% Since Beginning Of Nov.,2017-11-27 11:52:00-05:00,ADMP,neutral
27195.0,"Benzinga's Top Upgrades, Downgrades For September 13, 2017",2017-09-13 09:21:00-04:00,ADMP,positive
27196.0,"Raymond James Initiates Coverage On Adamis Pharmaceuticals with Outperform Rating, Announces $7.00 Price Target",2017-09-13 07:37:00-04:00,ADMP,neutral
27197.0,Adamis Pharmaceuticals Attempts To Extend 4-Day Winning Streak,2017-08-23 13:39:00-04:00,ADMP,positive
27198.0,Mylan's Stock Is No Longer A Buy According To Analysts At Argus,2017-08-22 09:07:00-04:00,ADMP,negative
27199.0,Adamis Files to Offer ~2.83M Shares of Common Stock -424B3,2017-08-22 06:13:00-04:00,ADMP,positive
27200.0,Attention Biotech Investors: Keep Your Date With July PDUFA Action-Days,2017-07-05 11:01:00-04:00,ADMP,neutral
27201.0,22 Stocks Moving In Friday's Pre-Market Session,2017-06-16 08:28:00-04:00,ADMP,neutral
27202.0,Mylan Shares Down ~$0.14 Over Last Few Mins Following Adamis News Of FDA Approval For Epinephrine Shot,2017-06-15 14:36:00-04:00,ADMP,positive
27203.0,Adamis Pharma Shares To Resume Trade At 3 p.m. EDT,2017-06-15 14:34:00-04:00,ADMP,positive
27204.0,UPDATE: Adamis Says Epinephrine Injection Will Trade Under Name 'Symjepi',2017-06-15 14:33:00-04:00,ADMP,neutral
27205.0,Adamis Pharma Reports Received FDA Approval For Epinephrine Pre-Filled Syringe,2017-06-15 14:32:00-04:00,ADMP,positive
27206.0,"Adamis Pharma Shares Halted News Pending, Ahead Of PDUFA Date",2017-06-15 14:23:00-04:00,ADMP,positive
27207.0,A Peek At Adamis Ahead Of FDA Approval,2017-06-15 09:05:00-04:00,ADMP,positive
27208.0,Adamis Pharma Spikes to High of $4.50 After-Hours,2017-06-14 16:57:00-04:00,ADMP,neutral
27209.0,"Reminder: Adamis Pharmaceuticals Estimated PDUFA Date For Epinephrine Pre-Filled Syringe Is Tomorrow, June 15",2017-06-14 16:26:00-04:00,ADMP,neutral
27210.0,Adamas Pharma Drops to Low of $3.50 on Volume,2017-06-14 15:32:00-04:00,ADMP,negative
27211.0,Option Alert: Adamis Pharma Jun 5.0 Calls Sweep: 626 @  ASK  $0.60: 1678 traded vs 4859 OI:  Earnings 8/15 After Close (est)  $4.34 Ref,2017-06-02 12:06:00-04:00,ADMP,positive
27212.0,Tracking The Busy June PDUFA Calendar,2017-05-30 08:58:00-04:00,ADMP,neutral
27213.0,Adamas Pharma Pops to High of $3.78 on Volume,2017-05-17 11:18:00-04:00,ADMP,neutral
27214.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Werner Enterprises Shares Spike Higher,2017-04-21 14:33:00-04:00,ADMP,negative
27215.0,15 Biggest Mid-Day Losers For Friday,2017-04-21 13:31:00-04:00,ADMP,negative
27216.0,Mid-Day Market Update: CAI International Gains On Strong Results; Adamis Pharmaceuticals Shares Slide,2017-04-21 12:09:00-04:00,ADMP,positive
27217.0,Mid-Morning Market Update: Markets Edge Lower; General Electric Tops Q1 Estimates,2017-04-21 10:03:00-04:00,ADMP,positive
27218.0,Adamis Pharmaceuticals Prices 4.28M Offering At $3.50/Share,2017-04-21 09:13:00-04:00,ADMP,neutral
27219.0,25 Stocks Moving In Friday's Pre-Market Session,2017-04-21 08:31:00-04:00,ADMP,neutral
27220.0,Adamis Pharmaceuticals Reports Proposed Public Offering of Common Stock,2017-04-20 16:02:00-04:00,ADMP,neutral
27221.0,Adamis Pharma Reports FDA Acceptance of Resubmission of Epinephrine Pre-Filled Syringe NDA,2017-01-19 09:00:00-05:00,ADMP,positive
27222.0,"B. Riley Initiates Coverage On Adamis Pharmaceuticals at Buy, Announces $5.00 Target",2016-12-20 06:30:00-05:00,ADMP,neutral
27223.0,Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA,2016-12-16 09:00:00-05:00,ADMP,neutral
27224.0,30 Stocks With Three-Day Increasing Volume,2016-09-20 09:10:00-04:00,ADMP,neutral
27225.0,15 Stocks Which Rallied Three Days On Increasing Volume,2016-09-20 08:58:00-04:00,ADMP,neutral
27226.0,Adamas Pharma Shares Spiking Higher on Volume; Traders Circulating Positive Note,2016-09-02 14:30:00-04:00,ADMP,positive
27227.0,10 Biggest Mid-Day Losers For Monday,2016-08-29 13:11:00-04:00,ADMP,negative
27228.0,"Traders Attributing 6% Jump In Adamis Pharmaceutical To Positive Barron's Piece Out This Morning, Highlights Mylan's EpiPen Fallout As Beneficial For Adamis",2016-08-26 09:57:00-04:00,ADMP,positive
27229.0,Sabby Reports 7.73% Stake in Adamis Pharmaceuticals in 13G,2016-08-09 15:18:00-04:00,ADMP,neutral
27230.0,CVI Investments Reports 5.5% Stake In Adamis Pharmaceuticals,2016-08-08 12:57:00-04:00,ADMP,neutral
27231.0,Adamis Pharmaceuticals Files for Up to $17.5M Stock Shelf,2016-08-04 06:13:00-04:00,ADMP,neutral
27232.0,"Top Performing Industries For August 2, 2016",2016-08-02 10:47:00-04:00,ADMP,positive
27233.0,UPDATE: Adamis Says Decision by Allergan's Watson Follows Receipt of FDA CRL in June,2016-07-21 09:06:00-04:00,ADMP,neutral
27234.0,"UPDATE: Adamis Pharma Says Received Notice from Allergan Subsidiary, Watson Labs, of Termination of License Deal to Commercialize Co.'s Epinephrine PFS Candidate",2016-07-21 09:05:00-04:00,ADMP,neutral
27235.0,Adamis Pharma Offers Update on License Deal with Allergan,2016-07-21 09:04:00-04:00,ADMP,neutral
27236.0,Stocks Hitting 52-Week Lows,2016-06-20 10:30:00-04:00,ADMP,negative
27237.0,Mid-Afternoon Market Update: Helios and Matheson Analytics Jumps Amid News Of Merger With Zone Technologies; ProNAi Therapeutics Shares Drop,2016-06-06 14:31:00-04:00,ADMP,neutral
27238.0,Monday's 7 Biggest Mid-Day Losers,2016-06-06 12:44:00-04:00,ADMP,negative
27239.0,Mid-Day Market Update: Dow Surges Over 100 Points; Adamis Pharmaceuticals Shares Slide,2016-06-06 12:05:00-04:00,ADMP,positive
27240.0,These 3 Biotech Stocks Are Getting Killed Today,2016-06-06 10:58:00-04:00,ADMP,negative
27241.0,Mid-Morning Market Update: Markets Open Higher; Devon Energy To Sell Non-Core Upstream Assets For Around $1 Billion,2016-06-06 10:09:00-04:00,ADMP,positive
27242.0,10 Stocks Moving In Monday's Pre-Market Session,2016-06-06 08:30:00-04:00,ADMP,neutral
27243.0,FDA Advises Adamis Pharmaceuticals To Expand Human Factors And Reliability To Support Its NDA For Epinephrine Injection,2016-06-06 07:26:00-04:00,ADMP,positive
27244.0,FDA Responds to Adamis Pharma NDA: Human Factors Study Must Be Expanded,2016-06-06 06:46:00-04:00,ADMP,neutral
27245.0,"UPDATE: Watson to Obtain Commercial Rights for U.S. in Exchange for Upfront Fee, Potential Regulatory and Performance Based Milestone Payments Totaling up to $32.5M",2016-05-10 06:49:00-04:00,ADMP,neutral
27246.0,Adamis Pharmaceuticals Announces License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled Syringe,2016-05-10 06:47:00-04:00,ADMP,positive
27247.0,StreetSweeper Releases Report On Adamis Pharmaceuticals,2016-05-04 09:54:00-04:00,ADMP,neutral
27248.0,Eddie Glover Reports 5.7% Stake in Adamis Pharmaceuticals in 13D,2016-04-27 06:05:00-04:00,ADMP,neutral
27249.0,Adamis Pharmaceuticals Complete US Compounding Acquisition,2016-04-12 07:19:00-04:00,ADMP,neutral
27250.0,Adamis Pharmaceuticals Gains 20% Following Acquisition Of US Compounding,2016-03-29 10:23:00-04:00,ADMP,positive
27251.0,"Adamis Pharma Announces Acquisition of US Compounding, Terms Not Disclosed",2016-03-29 06:47:00-04:00,ADMP,neutral
27252.0,Stocks Hitting 52-Week Highs,2016-03-28 10:17:00-04:00,ADMP,neutral
27253.0,Adamis Pharmaceuticals Reports FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA,2016-01-14 16:05:00-05:00,ADMP,positive
27254.0,"Top Performing Industries For December 7, 2015",2015-12-07 10:31:00-05:00,ADMP,positive
27255.0,VAdamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA,2015-12-07 09:01:00-05:00,ADMP,neutral
27256.0,"Maxim Initiates Coverage on Adamis Pharmaceuticals at Buy, Announces $16.00 PT",2015-12-01 09:29:00-05:00,ADMP,neutral
27257.0,"Worst Performing Industries For August 7, 2015",2015-08-07 11:56:00-04:00,ADMP,negative
27258.0,Adamis Pharmaceuticals Provides Regulatory Update on Its Epinephrine Pre-Filled Syringe,2015-08-06 09:01:00-04:00,ADMP,neutral
27259.0,"Mizuho Securities Initiates Coverage on Adamis Pharmaceuticals at Buy, Announces $10.00 PT",2015-05-28 16:23:00-04:00,ADMP,positive
27260.0,Morning Market Gainers,2015-04-16 09:44:00-04:00,ADMP,neutral
27261.0,Adamis Pharma Announces Positive Clinical Results for Albuterol: Shows Primary Endpoint for FEV1 Met,2015-04-16 09:04:00-04:00,ADMP,positive
27262.0,"Worst Performing Industries For April 1, 2015",2015-04-01 11:11:00-04:00,ADMP,negative
27263.0,Morning Market Losers,2015-03-30 09:49:00-04:00,ADMP,negative
27264.0,Adamis Pharmaceuticals Receives CRL from FDA for Epinephrine Pre-Filled Syringe NDA,2015-03-27 17:44:00-04:00,ADMP,neutral
27265.0,Adamis Pharmaceuticals Halted; Pending News,2015-03-27 17:35:00-04:00,ADMP,neutral
27266.0,Adamis Pharmaceuticals Announces Positive Pharmacokinetic Study Results For Its Dry Powder Inhaler Product,2015-03-03 09:06:00-05:00,ADMP,positive
27267.0,Adamis Pharmaceutical ANnounces Positive Pharmacokinetic Results for Its Beclomethasone Dipropionate HFA Product,2015-02-24 09:01:00-05:00,ADMP,positive
27268.0,Adamis Pharmaceuticals Receives Notice of Allowance for US and Japanese Patents for Its Dry Powder Inhaler,2015-01-28 09:06:00-05:00,ADMP,neutral
27269.0,Morning Market Losers,2015-01-09 09:53:00-05:00,ADMP,negative
27270.0,Adamis Pharmaceuticals Announces Pricing of 2M Share Public Offering of Common Stock At $5/share,2015-01-09 09:05:00-05:00,ADMP,positive
27271.0,Adamis Pharmaceuticals Announces Public Offering of Common Stock,2015-01-08 16:36:00-05:00,ADMP,neutral
27272.0,"Adamis Pharma Reports Private Placement, Received Gross Cash Proceeds ~$5M",2014-08-19 17:07:00-04:00,ADMP,negative
27273.0,Stocks Hitting 52-Week Lows,2014-08-15 13:15:00-04:00,ADMP,negative
27274.0,Adamis Pharma Announces FDA Has Accepted Epinephrine NDA For Review,2014-07-29 09:15:00-04:00,ADMP,positive
27275.0,Adamis Pharmaceuticals Fills $50M Mixed-Shelf Offering,2014-06-23 17:25:00-04:00,ADMP,neutral
27276.0,UPDATE: Adamis Submits New Drug Application to FDA for Its Epinephrine Pre-Filled Syringe,2014-05-29 08:17:00-04:00,ADMP,neutral
27277.0,Runway Research Positive Blog Post on Adamis Pharmaceuticals,2013-12-30 09:38:00-05:00,ADMP,positive
27278.0,"Adamis Pharmaceuticals Announces Pricing of Public Offering of 3.72M Shares at $5.95, Listing on NASDAQ, Reverse Stock Split",2013-12-13 09:05:00-05:00,ADMP,positive
27279.0,Adamis Prostate Cancer Drug APC-200 Granted Patents in Singapore and South Africa   ,2011-09-22 09:30:00-04:00,ADMP,negative
